Adicet Bio, Inc. (ACET)
$5.61-2.26%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $52M
- Beta
- 1.63
- P/E (TTM)
- -0.55
- Short % float
- 5.92%
- Days to cover
- 1.1
- SI change
- +78.5%
- 1W
- -13.69%
- 1M
- -41.13%
- vs SPY 1W
- -14.85%
- vs SPY 1M
- -44.13%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ACET?
- LOPJLB’s latest quantitative signal on Adicet Bio, Inc. (ACET) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ACET in?
- Adicet Bio, Inc. (ACET) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Adicet Bio, Inc. (ACET) do?
- Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The companyâs strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the bo…